Selective laser trabeculoplasty
Low-energy pulses to the trabecular meshwork increase outflow. It can be used first line or added to drops.
LiGHT 2019Glaucoma Care · Laser
Lasers treat glaucoma at three different points: the trabecular meshwork, the iris and the ciliary body. Knowing what each one does, and the evidence behind it, helps you decide when to perform, refer or co-manage.
The procedures
Trabeculoplasty improves outflow, iridotomy opens a path around a narrow angle, and cyclophotocoagulation reduces aqueous production.
Low-energy pulses to the trabecular meshwork increase outflow. It can be used first line or added to drops.
LiGHT 2019BELKIN Vision's Eagle, cleared by the FDA in December 2023, delivers SLT through the limbus without a gonioscopy lens.
Ophthalmology TimesA small opening in the peripheral iris relieves pupillary block in angle closure or narrow angles at risk.
ZAP 2019Iridex's MicroPulse delivery on the Cyclo G6 platform treats the ciliary body through the sclera to lower production.
IridexTwo large randomized trials published in 2019 reshaped how laser is used early in care.
718 patients with untreated open-angle glaucoma or ocular hypertension were randomized to SLT first or drops first; 74.2% of the SLT group needed no drops at 36 months.
Eyes were within target at 93.0% of visits after SLT and 91.3% with drops, and no SLT patient needed glaucoma surgery compared with 11 in the drops arm.
In 889 bilateral angle-closure suspects, treated eyes progressed at 4.19 per 1,000 eye-years versus 7.97 in untreated eyes.
Because progression was uncommon, the authors suggested prophylactic iridotomy may not be needed for every suspect like those studied.
Co-management
Whether you perform the laser or refer it, the pre- and post-procedure work is the same.
Document the angle, pressure trend, OCT and fields, and why laser is preferred over another drop.
The laser is performed by an authorized provider. Pressure is commonly checked shortly afterward for a spike.
Recheck pressure at follow-up to judge the response, then continue the usual testing schedule.
| 65855 | Trabeculoplasty by laser surgery |
|---|---|
| 66761 | Iridotomy or iridectomy by laser surgery |
| 66710 | Ciliary body destruction, cyclophotocoagulation, transscleral |
| Global period | Check each code's global days, since post-op visits within the period are not separately billed |
SLT systems are sold by several manufacturers, and BELKIN Vision markets a non-contact direct SLT device. Lasers are purchased from the manufacturer, not through the wholesale catalog.
For many patients. In LiGHT, 74.2% of patients treated with SLT first needed no drops to stay at target at three years.
Yes, it is commonly repeated when the effect wears off. Decide based on response and the pressure target.
Not necessarily. The ZAP trial found a low rate of progression in angle-closure suspects, so the decision is individualized.
Lowering pressure by reducing aqueous production, often in patients who are not good candidates for, or have not responded to, other approaches.
In states that authorize it. The number has grown steadily, with West Virginia and Montana added in 2025.
Typically the pre-procedure evaluation and post-procedure pressure checks, under an agreement with the surgeon.
Use laser to reduce drop burden and improve adherence, and build a referral path for the procedures you do not perform.
Written for licensed eye care professionals. Procedure authority varies by state. Codes and global periods change; confirm current CPT descriptors and payer rules. Device names are trademarks of their manufacturers.